Skip to content

Clinical trials

Hypertension trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Country / region: South Korea Clear all

339 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20034
20044
20055
20066
200714
200811
200913
201014
201119
201223
201313
201425
201520
201612
201715
201817
201919
202014
202115
202219
202318
202415
202513
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed258
Unknown status38
Recruiting17
Terminated8
Active, not recruiting8
Not yet recruiting7
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chong Kun Dang Pharmaceutical54
Boryung Pharmaceutical Co., Ltd36
Hanmi Pharmaceutical Company Limited23
Boehringer Ingelheim16
Yuhan Corporation16
AstraZeneca14
Seoul National University Hospital12
Yonsei University12
Daewoong Pharmaceutical Co. LTD.11
Novartis Pharmaceuticals9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension339
Dyslipidemias51
Hyperlipidemias36
Essential Hypertension23
Diabetes Mellitus14
Diabetes Mellitus, Type 213
Cardiovascular Diseases8
Renal Insufficiency, Chronic8
Hypercholesterolemia7
Heart Failure6

Trials

Showing 51 to 75 of 339. Each trial links to its page on Pharma Observatory.

239 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.